Toepassingen van positron-emissietomografie in de oncologie

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 5, 1996, Pages 244-248

  Kole, A C ^a   Nieweg, O E ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; DIAGNOSTIC PROCEDURE; HUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN SYNTHESIS; SHORT SURVEY;

HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASMS, UNKNOWN PRIMARY; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0030067181     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ishiwata K, Vaalburg W, Elsinga PhH, Paans AMJ, Woldring MG. Metabolic studies with L-[1-14C]-tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET. J Nucl Med 1988;29:524-9.
2. Willemsen ATM, Waarde A van, Paans AMJ, Pruim J, Luurtsema G, Go KG, et al. In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C)-tyrosine and PET. J Nucl Med 1995;36:411-9.
3. Blanksma PK, Vaalburg W, Paans AMJ, Meeder J, Gilst WH van, Lie KI. Toepassing van positron-emissietomografie in de cardiologie: een metabole dimensie. Ned Tijdschr Geneeskd 1991;135:9-13
4. Nieweg OE. Potential applications of positron emission tomography in surgical oncology. Eur J Surg Oncol 1994;20:415-24.
5. Nolop KB, Rhodes CG, Brudin LH, Beany RP, Krausz T, Jones T, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987;60:2682-9.
6. Nieweg OE, Kim EE, Wong WH, Broussard WF, Singletary SE, Hortobagyi GN, et al. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993;71:3920-5.
7. Schelstraete K, Simons M, Deman J, Vermeulen FL, Slegers G, Vandecasteele C, et al. Uptake of 13N-ammonia by human tumours as studied by positron emission tomography. Br J Radiol 1982;55:797-804.
8. Schlag P, Lehner B, Strauss LG, Georgi P, Herfarth C. Scar or recurrent rectal cancer Positron emission tomography is more helpful for diagnosis than immunoscintigraphy Arch Surg 1989;124:197-200.
9. Syrota A, Duquesnoy N, Paraf A, Kellershohn C. The role of positron emission tomography in the detection of pancreatic disease. Radiology 1982;143:249-53.
10. Frey P, Townsend D, Flattet A, De Gautard R, Widgren S, Jeavons A, et al. Tomographic imaging of the human thyroid using 1241. J Clin Endocrinol Metab 1986;63:918-27.
11. Martiat Ph, Ferrant A, Labar D, Cogneau M, Bol A, Michel C, et al. In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography. J Nucl Med 1988;29:1633-7.
12. Griffeth LK, Dehdashti F, McGuire AH, McGuire DJ, Perry DJ, Moerlein SM, et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992;182:185-94.
13. Nagata Y, Yamamoto K, Hiraoka M, Abe M, Takahashi M, Akuta K, et al. Monitoring liver tumor therapy with [18F]FDG positron emission tomography. J Comput Assist Tomogr 1990;14:370-4.
14. Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 1988;61:1776-81.
15. Braams JW, Pruim J, Nikkels P, Roodenburg JLN, Boering G, Vaalburg W, et al. Detection of lymph node metastases in squamous head-neck cancer with MRI and FDG-PET. J Nucl Med 1993;34 Suppl:55P-6P.
16. Kole AC, Nieweg OE, Vermey A, Pruim J, Hoekstra HJ, Braams JW, et al. 'Whole body' PET: opsporing van onbekende primaire tumoren. Veldhoven: Nederlandse Vereniging voor Heelkunde. 1994.
17. Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Gunasekera R, et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989;13:829-31.
18. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis J Nucl Med 1994;35-1647-9.
19. Patronas NJ, Di Chiro G, Brooks RA, DeLaPaz RL, Kornblith PL, Smith BH, et al. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain Radiology 1982;144:885-9.
20. Penninckx F, Beets G, Schiepers C, Filez L, Kerremans R, Aerts R, et al. Clinical value of whole body positron emission tomography with 18F-fluoro-deoxy-glucose in recurrent colorecitl cancer. Eur J Surg Oncol 1994.20 334.
21. Kim EE, Chung SK, Haynie TP, Kim CG, Cho BJ, Podoloff DA, et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18, FDG PET. Radiographies 1992;12:269-79.
22. Nieweg OE, Hoekstra HJ, Pruim J, Schraffordt Koops H, Oldhoff J, Paans AMJ, et al. Detection and in vivo grading of soft tissue sarcomas with positron emission tomography. Br J Surg 1993;80:S68.
23. Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. 'Anatometabolic' tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993;34:1190-7.
24. Wahl RL, Cody RL, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma, initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1991;179-765-70.
25. Gupta NC, Bowman BM, Thorson A, Falk P, Rysary J, Christensen M, et al. F-18 fluorodeoxyglucose (FDG) PET for pre-operative staging of colorectal carcinoma. J Nucl Med 1992;33:975.
26. Gupta NC, Frank AR, Dewan NA, Redepenning LS, Rothberg ML, Mailliard JA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441-4.
27. Joensuu H, Ahonen A. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. J Nucl Med 1987;28:910-4.
28. Hawkins RA, Hoh C, Dahlbom M, Choi Y, Glaspy J, Tse N, et al. PET cancer evaluations with FDG J Nucl Med 1991;32:1555-8.
29. Ginkel RJ van, Hoekstra HJ, Nieweg OE, Molenaar WM, Pruim J, Paans AMJ, et al. FDG PET to evaluate the response to hyperthermic isolated limb perfusion for locally advanced soft tissue sarcoma. J Nucl Med 1996 [ter perse].
30. Doyle WK, Budinger TF, Valk PE, Levin VA, Gutin PH. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography J Comput Assist Tomogr 1987;11:563-70.
31. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988;29:1521-5.
32. Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991;32:1655-60.
33. Nieweg OE, Wong WH, Singletary SE, Hortobagyi GN, Kim EE. Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging and evaluation of chemotherapy. In: Squartini F, Bevilacqua G, Conte PF, Surbone A, editors. Breast cancer: from biology to therapy. 698th ed. New York: Ann NY Acad Sci, 1993:423-8.
34. Haberkorn U, Strauss LG, Dimitrakopoulou A, Seiffert E, Oberdorfer F, Ziegler S, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993;34:12-7.
35. Elsinga PH, Franssen EJF, Graaf WTA van der. Vries EGE de, Visser GM, Vaalburg W. Carbon-11 labelled daunorubicin: a tracer for the in vivo investigation of multi drug resistance. J Nucl Med 1994:35 Suppl:83P.
36. Haberkorn U, Strauss LG, Haag D, Seiffert E, Dimitrakopoulou A, Knopp M, et al. PET with fluor-18-deoxyglucose in human head and neck cancer: relation to flow cytometric data. Eur J Nucl Med 1990; 16.529.
37. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-9.
38. Poupeye EM, Goethals PP, Dams RF, Leenheer AP de, Eijkeren ME van. Evaluation of [11C]thymidine for measurement of cell proliferation in fast dividing tissues. Nucl Med Biol 1993;20:359-62.